Category: Cardiac Rhythm Management
The FDA says it will require automated external defibrillators to undergo its strict pre-market approval process.
St. Jude Medical's 4th-quarter and 2014 profits surge as its sales and earnings meet expectations on Wall Street.
The FDA approves St. Jude Medical's FlexAbility ablation catheter for treating cardiac fibrillation.
AliveCor, with CE Mark in hand, will roll out an updated app in the United Kingdom and Ireland that detects atrial fibrillation.
AliveCor said it plans to launch the latest version of its app to detect atrial fibrillation in the U.K. and Ireland after winning CE Mark approval in the European Union for the updated tech.
Medtronic launches a European clinical trial to evalute its Arctic Front Advance cryoablation balloon as a front-line treatment for atrial fibrillation.
St. Jude Medical launches a clinical trial to evaluate the use of ablation and cardiac rhythm management devices in treating ventricular tachycardia.
CardioFocus reports a funding round worth nearly $32 million and inks a Japanese distribution deal for its HeartLight laser ablation system for treating atrial fibrillation.
CardioFocus this week reported a funding round worth nearly $32 million and said it inked a distribution deal in Japan for its HeartLight laser ablation system for treating atrial fibrillation.